(Q33404971)
Statements
A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma (English)
B Chowbay
Q S Ng
C H Thng
S Hartono
T S Koh
D Poon
M K Ang
S Chang
19 December 2012